JP2008513524A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513524A5
JP2008513524A5 JP2007532749A JP2007532749A JP2008513524A5 JP 2008513524 A5 JP2008513524 A5 JP 2008513524A5 JP 2007532749 A JP2007532749 A JP 2007532749A JP 2007532749 A JP2007532749 A JP 2007532749A JP 2008513524 A5 JP2008513524 A5 JP 2008513524A5
Authority
JP
Japan
Prior art keywords
acid
release formulation
sustained release
sustained
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007532749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513524A (ja
JP5081622B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2005/001521 external-priority patent/WO2006032202A1/zh
Publication of JP2008513524A publication Critical patent/JP2008513524A/ja
Publication of JP2008513524A5 publication Critical patent/JP2008513524A5/ja
Application granted granted Critical
Publication of JP5081622B2 publication Critical patent/JP5081622B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007532749A 2004-09-21 2005-09-21 ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法 Expired - Lifetime JP5081622B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200410077961 2004-09-21
CN200410077961.9 2004-09-21
PCT/CN2005/001521 WO2006032202A1 (fr) 2004-09-21 2005-09-21 Formulation à libération lente et prolongée contenant un agoniste du récepteur de la dopamine et son procédé de préparation

Publications (3)

Publication Number Publication Date
JP2008513524A JP2008513524A (ja) 2008-05-01
JP2008513524A5 true JP2008513524A5 (https=) 2011-04-07
JP5081622B2 JP5081622B2 (ja) 2012-11-28

Family

ID=36089849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532749A Expired - Lifetime JP5081622B2 (ja) 2004-09-21 2005-09-21 ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法

Country Status (9)

Country Link
US (2) US8691277B2 (https=)
EP (1) EP1797871B1 (https=)
JP (1) JP5081622B2 (https=)
KR (1) KR20070059161A (https=)
AU (1) AU2005287743B2 (https=)
CA (1) CA2581143C (https=)
ES (1) ES2536460T3 (https=)
PL (1) PL1797871T3 (https=)
WO (1) WO2006032202A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
PT2010184E (pt) * 2006-04-06 2013-04-03 Nupathe Inc Implantes para o tratamento dos estados associados à dopamina
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
JP2009539941A (ja) * 2006-06-16 2009-11-19 ソルベイ・フアーマシユーチカルズ・ベー・ブイ Ｓｌｖ３０８およびｌ−ｄｏｐａを含んでなる組み合わせ製剤
TWI392670B (zh) 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
WO2008009665A1 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
EP2291178A4 (en) * 2008-06-09 2013-07-24 Supernus Pharmaceuticals Inc PRAMIPEXOL FORMULATIONS WITH CONTROLLED RELEASE
EP2452677A1 (en) 2008-09-29 2012-05-16 Wockhardt Limited Extended release dosage form of ropinirole
FR2936710B1 (fr) * 2008-10-07 2011-01-07 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
EP2448411A4 (en) * 2009-07-02 2012-11-28 Supernus Pharmaceuticals Inc METHOD OF TREATING A NEUROLOGICAL DISORDER
WO2011012723A1 (en) 2009-07-31 2011-02-03 Ascendis Pharma As Injectable sustained release compositions comprising a pramipexole prodrug
WO2011012721A1 (en) 2009-07-31 2011-02-03 Ascendis Pharma As Carrier linked pramipexole prodrugs
DE102010014113A1 (de) * 2010-04-07 2011-10-13 Acino Ag Freisetzungsverfahren für Implantate
KR101481643B1 (ko) * 2010-11-25 2015-01-12 산동 루예 파마슈티칼 컴파니 리미티드 로티고틴, 이의 유도체 또는 로티고틴 또는 이의 유도체의 약제학적으로 허용가능한 염의 조성물
WO2012074988A1 (en) * 2010-12-02 2012-06-07 Ratiopharm Gmbh Rotigotine ionic liquid
US9956201B2 (en) 2014-07-21 2018-05-01 Spriaso Llc Compositions comprising bioreversible derivatives of hydroxy N-substituted-2-aminotetralins, and related dosage forms
WO2018096560A1 (en) 2016-11-23 2018-05-31 Cipla Limited Long acting depot formulation for the continuous dopaminergic stimulation
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide
KR102212722B1 (ko) * 2019-12-23 2021-02-08 환인제약 주식회사 로피니롤을 포함하는 마이크로스피어 및 이를 함유하는 주사제 조성물
JPWO2025243901A1 (https=) * 2024-05-21 2025-11-27

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166800A (en) * 1977-08-25 1979-09-04 Sandoz, Inc. Processes for preparation of microspheres
JP2651320B2 (ja) 1992-07-16 1997-09-10 田辺製薬株式会社 徐放性マイクロスフェア製剤の製造方法
DE69734060T2 (de) * 1996-05-24 2006-06-29 Angiotech Pharmaceuticals, Inc., Vancouver Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
JPH10167968A (ja) * 1996-10-09 1998-06-23 Takeda Chem Ind Ltd マイクロパーティクルの製造法
EP0930874A2 (en) 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. A method for producing a microparticle
JP4642946B2 (ja) * 1996-12-20 2011-03-02 アルザ コーポレイション ゲル組成物および方法
JP3663271B2 (ja) * 1997-01-24 2005-06-22 シュバルツ ファルマ アクチェンゲゼルシャフト 新規の分枝鎖エステル及びその製法
IL140899A0 (en) * 1998-07-17 2002-02-10 Skyepharma Inc Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof
ATE303795T1 (de) * 1998-12-16 2005-09-15 Aventis Pharma Inc In biologisch abbaubare polymere eingekapselter serotoninrezeptor-antagonist und deren herstellungsverfahren
US6455526B1 (en) * 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
GB9828861D0 (en) 1998-12-31 1999-02-17 Danbiosyst Uk Compositions
EP1110372B1 (en) 1999-07-09 2006-09-20 BTS Holding International B.V. Optical scanning apparatus with switchable resolution
AU2001252588A1 (en) * 2000-04-28 2001-11-12 Tanabe Seiyaku Co., Ltd. Method for preparing microsphere
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10055742B4 (de) * 2000-11-10 2006-05-11 Schwarz Pharma Ag Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen
NZ528994A (en) * 2001-04-26 2006-02-24 Control Delivery Sys Inc Sustained release drug delivery system containing codrugs
KR20050086736A (ko) * 2002-11-18 2005-08-30 폴리머릭스 코포레이션 신규 중합체를 이용하는 의학용 장치
PT1610791E (pt) * 2003-03-31 2011-05-23 Titan Pharmaceuticals Inc Dispositivo polim?rico implant?vel para liberta??o sustentada de agonista da dopamina
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen

Similar Documents

Publication Publication Date Title
JP2008513524A5 (https=)
JP5081622B2 (ja) ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法
CN100563658C (zh) 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂
EP2327397A2 (en) Method for manufacturing sustained release microsphere by solvent flow evaporation method
CN103209704A (zh) 有机化合物
WO2014207664A2 (en) Stable pharmaceutical composition of asenapine
JP2016513721A5 (https=)
JP2006514923A (ja) 注射可能な新規なデポ製剤
JP2016527308A (ja) エンテカビル微小球及びこれを含む非経口投与用医薬組成物
KR101663561B1 (ko) 서방출성 미립구의 제조방법
CN113226288B (zh) 纳曲酮注射型缓释制剂
CN1762495B (zh) 含有多巴胺受体激动剂类药物的长效缓释制剂及其制备工艺
CN115942935B (zh) 包括氯胺酮的微球制剂及其制备和使用方法
KR20230036886A (ko) 생분해성 고분자를 이용한 서방형 미립구 및 이의 제조방법
CA3143442A1 (en) Conjugates of heteroaromatic nitrogen-comprising compounds
CA3236690A1 (en) Sustained-release injectable composition containing naltrexone and method for preparing same
CA3236685A1 (en) Method for preparing microparticles containing poorly soluble drugs
KR102793673B1 (ko) 바리시티닙을 포함하는 장기지속형 미립구의 제조 방법 및 이의 제조 방법으로 제조된 바리시티닙을 포함하는 장기지속형 미립구
KR20230032772A (ko) 아픽사반을 함유하는 서방성 미립구
WO2006066509A1 (fr) Préparation microsphérique à libération prolongée injectable de dérivés de 3,3-diphénylpropylamine servant d'antagonistes du récepteur muscarinique
CN1857220B (zh) 一种抗结核病药物缓释剂
WO2025101020A1 (ko) 패티게이션 기술을 적용한 쿠에티아핀-지방산 접합체 나노입자 및 이의 장기 지속형 주사제 용도
HK40047988A (en) Naltrexone injectable sustained release formulation
JPWO2001005795A1 (ja) 頻尿もしくは尿失禁の治療または予防剤
HK1092054A (en) Novel injectable depot formulations